Literature DB >> 7934845

A Mycobacterium leprae-specific gene encoding an immunologically recognized 45 kDa protein.

T F Rinke de Wit1, J E Clark-Curtiss, F Abebe, A H Kolk, A A Janson, M van Agterveld, J E Thole.   

Abstract

By screening a Mycobacterium leprae lambda gt11 expression library with a serum from an Ethiopian lepromatous leprosy (LL) patient a clone was isolated (LL4) belonging to hybridization group III of a panel of previously isolated M. leprae clones. Members of this hybridization group encode a serologically recognized 45 kDa protein. The complete DNA sequences of the partially overlapping clones LL4 and L1 (hybridization group III) are presented and these revealed the presence of an open reading frame (ORF) predicting a protein with a molecular size of 42,448 Da. Southern hybridizations on total genomic DNA of M. leprae, Mycobacterium tuberculosis and eight atypical mycobacteria showed that the LL4 DNA fragment is specific for M. leprae DNA even under low-stringency conditions. The M. leprae specificity of LL4 DNA was further confirmed by the polymerase chain reaction using four different sets of primers. Western blotting analyses showed that the M. leprae 45 kDa protein is frequently recognized by antibodies from leprosy patients and that this recognition is specific since no antibodies could be detected in sera of tuberculosis patients. T-cell proliferation assays also demonstrated T-cell recognition by leprosy patients and healthy contacts of the M. leprae 45 kDa protein. The specificity of the LL4 DNA region and the 45 kDa antigen that is encoded by hybridization group III could provide unique tools for the development of M. leprae-specific immunological and DNA reagents.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7934845     DOI: 10.1111/j.1365-2958.1993.tb00953.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  4 in total

1.  Presence of human T-cell responses to the Mycobacterium leprae 45-kilodalton antigen reflects infection with or exposure to M. leprae.

Authors:  A Macfarlane; R Mondragon-Gonzalez; F Vega-Lopez; B Wieles; J de Pena; O Rodriguez; R Suarez y de la Torre; R R de Vries; T H Ottenhoff; H M Dockrell
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  A postgenomic approach to identification of Mycobacterium leprae-specific peptides as T-cell reagents.

Authors:  H M Dockrell; S Brahmbhatt; B D Robertson; S Britton; U Fruth; N Gebre; M Hunegnaw; R Hussain; R Manandhar; L Murillo; M C Pessolani; P Roche; J L Salgado; E Sampaio; F Shahid; J E Thole; D B Young
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Human T cell responses to peptides of the Mycobacterium leprae 45-kD serine-rich antigen.

Authors:  S Brahmbhatt; R Hussain; S Zafar; G Dawood; T H M Ottenhoff; J W Drijfhout; G Bothamley; S Smith; F V Lopez; H M Dockrell
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

4.  Use of a whole blood assay to evaluate in vitro T cell responses to new leprosy skin test antigens in leprosy patients and healthy subjects.

Authors:  R E Weir; P J Brennan; C R Butlin; H M Dockrell
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.